加载中
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
前收盘价
US$6.22
−US$0.15 · -2.35%
盘后
US$6.22
US$0.00 · 0.00%
10月12日 16:10 ET
盘中时间采用ET。市场数据可能有所延迟。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日内区间
当前US$6.22
52周区间
当前US$6.22
盘中时间采用ET。市场数据可能有所延迟。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日内区间
当前US$6.22
52周区间
当前US$6.22
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 5843.5万 USD | 5349.4万 USD | 4216.4万 USD | 3535.8万 USD | 3445.9万 USD |
| 销货成本 | 3131.3万 USD | 2764.3万 USD | 2105.7万 USD | 1540.3万 USD | 1662.6万 USD |
| 毛利 | 2712.2万 USD | 2585.1万 USD | 2110.7万 USD | 1995.5万 USD | 1783.3万 USD |
| 研究与开发 | 562.2万 USD | 532.9万 USD | 613.9万 USD | 1181.4万 USD | 1235.8万 USD |
| 销售、一般及管理费用 | 4515.7万 USD | 2648.8万 USD | 2610万 USD | 2717万 USD | 2388.7万 USD |
| 营业费用 | 5170万 USD | 3651.6万 USD | 3333.6万 USD | 4013.2万 USD | 3748.5万 USD |
| 利息收入 | 9.1万 USD | 10.3万 USD | 8.5万 USD | 1.7万 USD | 3.4万 USD |
| 折旧和摊销 | 450.2万 USD | 393.1万 USD | 351.5万 USD | 340.6万 USD | 276.4万 USD |
| 营业利润 | −2457.8万 USD | −1066.5万 USD | −1222.9万 USD | −2017.7万 USD | −1965.2万 USD |
| 净利润 | −3428万 USD | −3140.4万 USD | −1438.3万 USD | −1991.4万 USD | −1960.1万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$12.00
上涨空间 92.93%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI231.54万0.00%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard Extended Market ETFVXF96.06万0.00%954亿 USD0.05%US$233.52-0.63%
Dimensional - US Small Cap ETFDFAS24.86万0.00%338.69亿 USD0.31%US$78.17-0.23%
iShares Micro-Cap ETFIWC19.62万0.01%13.17亿 USD0.60%US$181.66-0.73%
Dimensional - US Targeted Value ETFDFAT14.07万0.00%301.22亿 USD0.33%US$67.42+0.22%
U.S. Micro Cap Portfolio ETFDFMC8.68万0.00%75.58亿 USD0.43%US$57.70-0.20%
Avantis U.S. Small Cap Equity ETFAVSC6427.33—30.82亿 USD0.25%US$69.97-0.01%
Dimensional - US Core Equity 2 ETFDFAC4344.340.00%885.96亿 USD0.21%US$45.31-0.04%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Micro-Cap ETFIWCDimensional - US Targeted Value ETFDFATU.S. Micro Cap Portfolio ETFDFMCAvantis U.S. Small Cap Equity ETFAVSCDimensional - US Core Equity 2 ETFDFACAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
